A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2026

Conditions
Skin Resurfacing
Interventions
DEVICE

Fraxel® FTX Laser System

"The Fraxel Laser System has two fiber-laser sources that are contained in a single Console. The Console is electrically connected to the facility power source. Laser energy produced by the unit is delivered to the tissue through the Handpiece, which is connected to the Console by the Handpiece Cable. Treatments are delivered through removable, disposable Treatment Tips which attach to the Handpiece. A Treatment Key is required to activate treatments and is inserted into the port on the side of the Touchscreen.~The system includes two lasers with wavelengths of 1550 nm and 1927 nm. The two-wavelength option allows for targeted treatment of different tissue depths, and the wavelength can be selected through the Console Touchscreen. Interchangeable Tips allow for treatment of both small and large areas."

Trial Locations (1)

77004

Dermatology and Laser Surgery Center, Houston

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT07214272 - A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing | Biotech Hunter | Biotech Hunter